Nutex Health (NASDAQ:NUTX) Coverage Initiated at B. Riley Financial

Equities research analysts at B. Riley Financial initiated coverage on shares of Nutex Health (NASDAQ:NUTX) in a research report issued on Friday. The brokerage set a “buy” rating and a $290.00 price target on the stock. B. Riley Financial’s target price indicates a potential upside of 94.50% from the stock’s previous close.

NUTX has been the subject of a number of other reports. Wall Street Zen raised shares of Nutex Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Lake Street Capital assumed coverage on Nutex Health in a research note on Tuesday, June 2nd. They issued a “buy” rating and a $235.00 price target on the stock. Finally, Weiss Ratings upgraded Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, May 4th. Three analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $243.33.

Nutex Health Price Performance

NUTX opened at $149.10 on Friday. The company has a quick ratio of 3.12, a current ratio of 3.14 and a debt-to-equity ratio of 0.66. The stock has a market cap of $1.03 billion, a P/E ratio of 11.52 and a beta of 0.26. The company has a fifty day simple moving average of $128.09 and a 200 day simple moving average of $130.09. Nutex Health has a 12 month low of $77.21 and a 12 month high of $193.07.

Nutex Health (NASDAQ:NUTX) last released its quarterly earnings results on Thursday, April 30th. The company reported $6.52 earnings per share for the quarter, beating the consensus estimate of $3.99 by $2.53. Nutex Health had a net margin of 10.95% and a return on equity of 23.50%. The company had revenue of $216.49 million during the quarter, compared to analysts’ expectations of $227.80 million.

Institutional Trading of Nutex Health

A number of institutional investors have recently made changes to their positions in NUTX. Pertento Partners LLP acquired a new position in Nutex Health during the third quarter worth $27,940,000. Topline Capital Management LLC lifted its position in Nutex Health by 80.0% during the 3rd quarter. Topline Capital Management LLC now owns 556,567 shares of the company’s stock worth $57,505,000 after buying an additional 247,436 shares in the last quarter. Millennium Management LLC lifted its position in Nutex Health by 191.1% during the 3rd quarter. Millennium Management LLC now owns 93,396 shares of the company’s stock worth $9,650,000 after buying an additional 61,308 shares in the last quarter. Empowered Funds LLC acquired a new position in shares of Nutex Health during the 1st quarter worth about $3,084,000. Finally, SG Americas Securities LLC boosted its stake in shares of Nutex Health by 3,232.6% during the 1st quarter. SG Americas Securities LLC now owns 30,360 shares of the company’s stock worth $2,885,000 after buying an additional 29,449 shares during the last quarter. Institutional investors own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight?loss services and behavioral health support. By combining in?person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost?effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail?anchored centers, offering treatment for non?life?threatening injuries and illnesses, preventive screenings and basic primary care.